Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endothelial Cell-Activating Antibodies in COVID-19.
Shi H, Zuo Y, Navaz S, Harbaugh A, Hoy CK, Gandhi AA, Sule G, Yalavarthi S, Gockman K, Madison JA, Wang J, Zuo M, Shi Y, Maile MD, Knight JS, Kanthi Y. Shi H, et al. Among authors: shi y. Arthritis Rheumatol. 2022 Jul;74(7):1132-1138. doi: 10.1002/art.42094. Epub 2022 May 27. Arthritis Rheumatol. 2022. PMID: 35174669 Free PMC article.
Endothelial cell-activating antibodies in COVID-19.
Shi H, Zuo Y, Navaz S, Harbaugh A, Hoy CK, Gandhi AA, Sule G, Yalavarthi S, Gockman K, Madison JA, Wang J, Zuo M, Shi Y, Maile MD, Knight JS, Kanthi Y. Shi H, et al. Among authors: shi y. medRxiv [Preprint]. 2022 Feb 2:2021.01.18.21250041. doi: 10.1101/2021.01.18.21250041. medRxiv. 2022. PMID: 33501469 Free PMC article. Updated. Preprint.
Continuation, reduction, or withdrawal of tofacitinib in patients with rheumatoid arthritis achieving sustained disease control: a multicenter, open-label, randomized controlled trial.
Wang M, Xue Y, Du F, Ma L, Lu LJ, Jiang L, Tao YL, Yang C, Shi H, Liu H, Cheng X, Ye J, Su Y, Zhao D, Dai SM, Teng J, Hu Q. Wang M, et al. Among authors: shi h. Chin Med J (Engl). 2023 Feb 5;136(3):331-340. doi: 10.1097/CM9.0000000000002561. Chin Med J (Engl). 2023. PMID: 36848153 Free PMC article. Clinical Trial.
Inactivated SARS-CoV-2 vaccine does not increase the risk of relapse in patients with clinically inactive adult-onset Still's disease.
Hong X, Pan H, Su Y, Hu Q, Sun Y, Liu H, Cheng X, Ye J, Shi H, Meng J, Zhou Z, Jia J, Liu T, Wang M, Chen X, Ma Y, Tang Z, Wang F, Zhang H, You Y, Zhu D, Chen L, Yang C, Teng J, Chi H. Hong X, et al. Among authors: shi h. Rheumatology (Oxford). 2023 Jun 1;62(6):2262-2266. doi: 10.1093/rheumatology/keac620. Rheumatology (Oxford). 2023. PMID: 36282541 Free PMC article.
15,137 results
You have reached the last available page of results. Please see the User Guide for more information.